News Explainer

Scientists warn that it will take multiple methods to stop the disease, which is also known as breakbone fever and was once confined to the tropics.

The post-COVID travel boom combined with a warm summer have led to dengue outbreaks in Italy and France.

Advisers to the US regulatory agency will examine the safety profile of a CRISPR-based treatment for sickle-cell disease.

Recent studies evaluate risks associated with drugs such as Wegovy and Mounjaro.

Nature talks to experts about how messenger RNA is transforming medicine.

Tens of thousands of federal researchers might have to stop work on 1 October — but the shutdown’s effects could ripple well beyond government.

Dolly-style animal cloning underpins CRISPR livestock, but changes loom for the field.

Nature explores the United Kingdom and European Union’s research agreements, brokered through seven years of rollercoaster negotiations.

Climate change, civil war and international sanctions all contributed to the devastation caused by some of Libya’s worst flooding ever, researchers say.

The quake, which has killed thousands, was unusually large for Morocco and struck a region where most buildings are not earthquake-resilient.

In just two weeks, the Indian mission has made some surprising discoveries about the composition of the Moon

Researchers say safety concerns over RAAC concrete in UK schools could be “the tip of the iceberg”.

Nature looks at the detective work required to confirm a controversial claim of finding interstellar debris.

Aditya-L1 will join other spacecraft from Europe and the United States in an attempt to understand our stormy star.

Research is under way to determine whether the mutation-laden lineage BA.2.86 has the potential for global spread — or whether it is nothing to worry about.

The planet has warmed 1.2 ºC on average, but that’s enough to produce big extremes.

Wildfires are not new to Hawaii but they are becoming increasingly devastating. More traditional land use and better data dissemination could help to prevent future tragedies.

Clinical-trial data suggest that semaglutide, sold under the name Wegovy, slashes risk of heart attacks and other cardiovascular incidents.

The creatures at the bottom of the ocean are little-studied, but emerging data hint at long-term damage from efforts to harvest metals on the sea floor.

More research is needed to investigate a potential link between the common sweetener and cancer.